Michael Friedman

Michael Friedman

Director/Board Member at MANNKIND CORPORATION

Net worth: 49 023 $ as of 2026-02-27

82 year
Health Technology
Consumer Services
Government

Profile

Michael A. Friedman is the founder of Cytovia Therapeutics, Inc. Current positions include President & Chief Executive Officer at City of Hope National Medical Center since 2003, Independent Director at MannKind Corp.
since 2003, Associate Director at National Cancer Institute since 1983, Director at Los Angeles Opera Co., Director at California Institute for Regenerative Medicine, Independent Non-Executive Director at Smith & Nephew A, Director at Sermonix Pharmaceuticals LLC since 2019, Director at FaceTec, Inc. since 2020, Partner & Director at Pure Green Agriculture, Inc. since 2017, Director at Cytovia, Inc. (Massachusetts), Trustee at Tulane University (Louisiana), and Managing Partner at Ignite Farm LLC since 2014.
Former positions include Independent Director at Celgene Corp.
from 2011 to 2019, Director at Rite Aid Corp.
in 2009, Director at Darden Restaurants, Inc. from 2006 to 2011, Independent Director at Intuitive Surgical, Inc., Independent Non-Executive Director at Smith & Nephew plc from 2013 to 2019, Director at Cancer Research Institute from 1981 to 1983, Director-Cancer Research Institute at The University of California, San Francisco, Associate Director at National Institutes of Health, Director at California Healthcare Institute, Director at National Comprehensive Cancer Network, Inc., Director at The Golf Channel LLC from 2011 to 2014, Director at Trumpet Advertising Services, Inc. from 1999 to 2001, Senior Vice President at G.D.
Searle & Co., Inc. from 1999 to 2001, SVP-Medical, Public Policy, Research & Development at Pharmacia Corp.
from 1999 to 2003, Deputy Commissioner-Operations at US Food & Drug Administration from 1995 to 1999, and Chief Medical Officer-Biomedical Preparedness at Pharmaceutical Research & Manufacturers of America.
Education includes an undergraduate degree from Tulane University (Louisiana) and a doctorate from The University of Texas Southwestern Medical Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-05-13 14,946 ( 0% ) 49 023 $ 2026-02-27

Michael Friedman active positions

CompaniesPositionStart
MANNKIND CORPORATION Director/Board Member 2003-11-30
Director/Board Member 2016-12-31
Director/Board Member 2019-12-31
Private Equity Investor 2014-08-31
Director/Board Member -
Founder -
Director/Board Member 2019-04-22
Director/Board Member -
Director/Board Member -
░░░░ ░░ ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Former positions of Michael Friedman

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Michael Friedman's experience

Training of Michael Friedman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

30

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies30

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Health Services

Consumer Services

Consumer Services

Miscellaneous

Government

Commercial Services

Government

Health Technology

Health Technology

Government

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Technology Services

Health Technology

Commercial Services

Process Industries

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Friedman
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW